Epoch Investment Partners, Inc. Charles River Laboratories International, Inc. Transaction History
Epoch Investment Partners, Inc.
- $19.4 Billion
- Q4 2024
A detailed history of Epoch Investment Partners, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Epoch Investment Partners, Inc. holds 49,066 shares of CRL stock, worth $5.24 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
49,066
Previous 9,094
439.54%
Holding current value
$5.24 Million
Previous $1.79 Million
405.7%
% of portfolio
0.05%
Previous 0.01%
Shares
24 transactions
Others Institutions Holding CRL
# of Institutions
700Shares Held
50.8MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$658 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$544 Million0.02% of portfolio
-
State Street Corp Boston, MA2.18MShares$233 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$193 Million0.56% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.81MShares$193 Million0.79% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $5.44B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...